Delivery Order HHSO100201300018I-HHSO10033003T
Award Date
6/11/15
Potential Completion Date
6/10/17
Potential Value
$6.2M
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Alachua, FL 32615, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $4,761,491.00 cost-plus-fixed-fee contract is a delivery order under the Fill and Finish Manufacturing Network (FFMN) Indefinite Delivery Vehicle (IDV). The contract is for the aseptic fill and finish manufacturing of succinylcholine chloride injection solution into 10 mL...
This is a definitive contract awarded by the Department of the Army's Joint PEO Chemical and Biological Defense, a defense agency, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $366,290,602.35 cost-plus-fixed-fee contract is for the Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) Capability, with a period of performance through October 31, 2023. As a prime contractor, Resilience has provided a range of goods and services related...
This is a $799,780 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for the development of analytical methods, upstream and downstream manufacturing processes, scale-up production, and release testing for the LNA14 product. This delivery order falls under a larger...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The $29,026,970.00 cost-plus-fixed-fee contract was awarded on September 9, 2019 to perform work under HHS-NIH-NIAID-BAA2018. The contract has an ultimate completion date of August 17, 2024 and does not have a set-aside designation....
This is a prime contract award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services. The $14,898,362.53 cost-plus-fixed-fee contract is for biomedical research and development. It has a period of performance through December 31, 2011 and does not have a set-aside designation. Resilience Government Services is a technology-focused...
This is a cost-plus-fixed-fee Delivery Order awarded by the Joint Program Executive Office for Chemical and Biological Defense, a component of the U.S. Department of the Army, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $107,935,344 award supports the clinical development of an FDA-licensed monoclonal antibody countermeasure for exposure to botulinum neurotoxin. The work will involve tasks such as clinical trials, process development, and...
This federal contract award, W911SR22D0009|W911SR22F0073, was issued by the Joint Program Executive Office for Chemical and Biological Defense, a Defense agency, to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The $4,861,155.86 contract is a Delivery Order under a Cost Plus Fixed Fee contract type, with a period of performance ending on February 28, 2025. The contract supports DS Process Characterization, which likely refers to characterization and development of...
This is a federal contract award from the U.S. Army Medical Command (MEDCOM) to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., a technology-focused biomanufacturing company. The $970,700.00 Cost Plus Fixed Fee contract is for research and development work related to the Telemedicine and Advanced Technology Research Center (TATRC) program. The contract has no set-aside designation and has an ultimate completion date of September 30, 2013. Resilience Government...
This is a $190,241,861.21 Other Transaction Agreement awarded by the Department of the Army's Joint PEO Chemical and Biological Defense to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.), a technology-focused biomanufacturing company. The contract does not have a set-aside designation. The agreement, awarded on February 21, 2020, supports the development and manufacturing of medical countermeasures against biological threats and COVID-19. Resilience has provided...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $5,107,357.36 Other Transaction Agreement to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., a technology-focused biomanufacturing company. The contract, which has no set-aside designation, is for the development of a "Plasmid Platform Protype" and is part of a larger $5.7 million Indefinite Delivery Vehicle aimed at transferring capabilities to...